43 results on '"Sehanobish, Esha"'
Search Results
2. The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD)
3. Aspirin-exacerbated respiratory disease is associated with variants in filaggrin, epithelial integrity, and cellular interactions
4. New concepts for the pathogenesis and management of aspirin-exacerbated respiratory disease
5. Acute and Longer-Term Effects of COVID-19 on Auditory and Vestibular Symptoms
6. Elaborate biologic approval process delays care of patients with moderate-to-severe asthma
7. Progression of Aspirin Exacerbated Respiratory Disease: A Cohort Study
8. During aspirin desensitization, omitting repeated provoking aspirin dose is safe
9. During aspirin desensitization, omitting repeated provoking aspirin dose is safe
10. In Silico Approaches to Identify Mutagenesis Targets to Probe and Alter Protein–Cofactor and Protein–Protein Functional Relationships
11. Analytical Methods for Assessing the Effects of Site-Directed Mutagenesis on Protein–Cofactor and Protein–Protein Functional Relationships
12. iNKT cells are enriched in inflammatory infiltrates of chronic rhinosinusitis with nasal polyposis
13. Lengthy Process Of Biologic Approval And Administration Delays Treatment Of Patients With Moderate-To-Severe Asthma
14. Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome
15. Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize NSAID-exacerbated respiratory disease
16. Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non‐steroidal anti‐inflammatory drug exacerbated respiratory disease
17. COVID-19 in a series of patients with aspirin-exacerbated respiratory disease
18. A traditional painkiller as a probe for microheterogeneity in 1-propanol–water mixtures
19. Disrupted epithelial barrier in nasal polyps characterizes aspirin exacerbated respiratory disease
20. sj-pdf-1-ajr-10.1177_19458924211004800 - Supplemental material for COVID-19-Induced Anosmia and Ageusia Are Associated With Younger Age and Lower Blood Eosinophil Counts
21. Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
22. COVID-19-Induced Anosmia and Ageusia Are Associated With Younger Age and Lower Blood Eosinophil Counts
23. Binding of Cu(II) complexes of oxicam NSAIDs to alternating AT and homopolymeric AT sequences: differential response to variation in backbone structure
24. Risk Factors Associated With COVID-19 Related Anosmia And Ageusia
25. Loss of sense of smells associated with sour taste is a possible diagnostic marker for COVID-19
26. New concepts for the pathogenesis and management of aspirin-exacerbated respiratory disease.
27. Lung Function Change In Aspirin Exacerbated Respiratory Disease (AERD) And In Aspirin-Tolerant Asthma Patients
28. Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non‐steroidal anti‐inflammatory drug exacerbated respiratory disease.
29. Structure and Enzymatic Properties of an Unusual Cysteine Tryptophylquinone-Dependent Glycine Oxidase from Pseudoalteromonas luteoviolacea
30. Structure and Enzymatic Properties of an Unusual Cysteine Tryptophylquinone-Dependent Glycine Oxidase from Pseudoalteromonas luteoviolacea
31. The Rv2633c protein of Mycobacterium tuberculosis is a non-heme di-iron catalase with a possible role in defenses against oxidative stress
32. Roles of Copper and a Conserved Aspartic Acid in the Autocatalytic Hydroxylation of a Specific Tryptophan Residue during Cysteine Tryptophylquinone Biogenesis
33. Roles of Conserved Residues of the Glycine Oxidase GoxA in Controlling Activity, Cooperativity, Subunit Composition, and Cysteine Tryptophylquinone Biosynthesis
34. Interaction of GoxA with Its Modifying Enzyme and Its Subunit Assembly Are Dependent on the Extent of Cysteine Tryptophylquinone Biosynthesis
35. Roles of active site residues in LodA, a cysteine tryptophylquinone dependent ε-lysine oxidase
36. Site-Directed Mutagenesis of Gln103 Reveals the Influence of This Residue on the Redox Properties and Stability of MauG
37. Steady-state kinetic mechanism of LodA, a novel cysteine tryptophylquinone-dependent oxidase
38. Sex, Ethnicity, BMI, and Environmental Exposures Associated With NSAID-Exacerbated Respiratory Disease Symptom Sequence
39. Structural and functional characterization of enzymes of a novel group of tryptophylquinone cofactor containing oxidases
40. The Rv2633c protein of Mycobacterium tuberculosis is a non-heme di-iron catalase with a possible role in defenses against oxidative stress.
41. During aspirin desensitization, omitting repeated provoking aspirin dose is safe.
42. In Silico Approaches to Identify Mutagenesis Targets to Probe and Alter Protein-Cofactor and Protein-Protein Functional Relationships.
43. Analytical Methods for Assessing the Effects of Site-Directed Mutagenesis on Protein-Cofactor and Protein-Protein Functional Relationships.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.